Cognitive Data in the Parkinson’s Progression Marker Initiative: Comparison of Normative Data Approaches Kathryn A. Wyman-Chick, Matthew J. Barrett, Phillip.

Slides:



Advertisements
Similar presentations
WMS-IV Wechsler Memory Scale - Fourth Edition
Advertisements

Use of efavirenz is not associated to an increased risk of neurocognitive impairment in HIV-infected patients Pinnetti C 1, Balestra P.
It is common practice for Neuropsychologists to administer the same tests on more than one occasion to document the progression of a patient’s cognitive.
NECTAC Webinar Series on Early Identification and Part C Eligibility Session 2: A Rigorous Definition of Developmental Delay March 10, 2010 Steven Rosenberg,
Aim 2: Organizational Approach  PD patients demonstrated greater disorganization in copy trial approach than controls; t(2.09), p
Neuropathology and Cognitive Scores Workgroup The role of vascular and Alzheimer’s Disease pathology in differential cognitive impairment among older adults.
Life course model of cognitive reserve Advanced Psychometrics Methods Web Conference – 2/16/10.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Barbara A. Wilson, Eve Greenfield, Linda Clare, Alan Baddeley, Janet Cockburn, Peter Watson, Robyn Tate, Sara Sopena, Rory Nannery & John Crawford (2008)
Challenges Assessing Functional Outcomes in Early Huntington Disease Jane Paulsen 1, Chiachi Wang 1, Kevin Duff 1, Roger Barker 2, Martha Nance 3, Leigh.
Correlation.
Standardization and Test Development Nisrin Alqatarneh MSc. Occupational therapy.
ABSTRACT METHODS RESULTS CONCLUSION Background: Georgia rates the quality of early childcare learning centers using a tiered quality improvement system.
Participants: Participants consisted of 26 (n = 26), healthy, college participants (5 males and 21 females) aged years. See Table 1. Protocol:
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
METHOD METHOD Long-Term Neuropsychological Functioning Following Mild Traumatic Brain Injury Nathalie C. Bérard and Dennis P. Alfano CONCLUSIONS The group.
Assessing Learners with Special Needs: An Applied Approach, 6e © 2009 Pearson Education, Inc. All rights reserved. Chapter 5: Introduction to Norm- Referenced.
Introduction ESTIMATING THE MINIMALLY IMPORTANT DIFFERENCE (MID) OF THE DIABETES HEALTH PROFILE (DHP-18) FOR TYPE 1 AND TYPE 2 DIABETES MELLITIS Brendan.
Does Anxiety Vary by Gender and Race During Adolescence? Alyson Cavanaugh, Kelly A. Cheeseman, and Christine McCauley Ohannessian University of Delaware.
Results Results Dillon C, MD, PhD; Vazquez G, MD, PhD ; Corrales A, MD; Allegri RF, MD, PhD; Taragano FE, MD, PhD. CEMIC University Hospital, SIREN, Department.
Statistics & Evidence-Based Practice
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Aka STEEL VALLEY SENIORS SURVEY (SVSS)
Introduction to ASCQ-MeSM
Friday Harbor Laboratory University of Washington August 22-26, 2005
: No disclosures #21634 Gender and ADHD in Ugandan Children: Comparison of Symptoms, Factor Structure, Prevalence, and Executive Functioning Matthew D.
CERAD immediate memory verbal fluency (animals)
Landon Marshall, Pharm. D. , Matt Hill, Pharm. D. , Jim Wilson, Pharm
Comparing Long -Term Neurocognitive Functioning in Dialysis and Transplantation – A Six Year Prospective Study. Deane, J. A.1, Griva, K.2, Stygall, J.3,
Service-related research: Therapy outcomes audit
Dependent-Samples t-Test
Applied Biostatistics: Lecture 4
Emergency department pediatric psychiatric services
Neurocognitive test battery
Wechsler Test-Retest Combinations
The BrainHealthRegistry
Conclusions- Discussion
Table 1. Summary of Study Measures
Brief Computerized Measures of Information Processing Speed are Sensitive to Multiple Sclerosis across the Lifespan M. Shaw1, C. Schwarz1, L.B. Krupp1,
MRC Dementias Platform UK
Volume 9, Pages 3-7 (December 2017)
Discussion Discuss your results.
Cognitive Biomarker of MS
Do as I Do, Not as I Say; Relations Between Narrative Script Production and Everyday Action Benjamin L. Deck, Ashley Hagerty, Emily Roll, Tania Giovannetti,
Association of Cortical Thickness to Cognitive Functioning in Late Life Depression Melissa Hirt, MA, David Bickford, BA, Alana Kivowitz, BA, Joseph Brewer,
Motor Perseveration Predicts Ideational Perseveration on the Wisconsin Card Sorting Test Matthew G Hall, M.S., Scott C Wollman, M.S., Lindsey A Frazier,
Sleep Disturbance as a Risk Factor for
Bowden, Shores, & Mathias (2006): Failure to Replicate or Just Failure to Notice. Does Effort Still Account for More Variance in Neuropsychological Test.
U C S F IN VETERANS WITH POSTTRAUMATIC STRESS DISORDER
FUNDING ACKNOWLEDGEMENT
Statistical Reporting Format
Relationships Between the Questionnaire for Impulsive-Compulsive Disorders in Parkinson Disease-Rating Scale and Measures of Executive Function David.
INTERPRETATION OF RESULTS & CONCLUSIONS
Irma Höijer, M.Sc., Doctoral Student
Neuro-psychological Tests
Hope S. Lancaster1  Stephen M. Camarata2
Introduction to ASCQ-Me®
Brief Visuospatial Memory Test- Revised™ (BVMT-R™) Ralph H
Designed for individuals ages 16 and older.
Turid Heiberg1,2, Bart Baekelandt3,
Introduction to ASCQ-Me®
Spanish and English Neuropsychological Assessment Scales - Guiding Principles and Evolution Friday Harbor Psychometrics Workshop 2005.
Statistics Problem Set III
Boston Naming Test predicts deterioration of cerebrospinal fluid biomarkers in pre-symptomatic Alzheimer’s disease Charleen Wilder, MA, Kristina Moncrieffe,
Alexa Stuifbergen, PhD, RN, FAAN Heather Becker, PhD, Frank Perez, PhD
Direct and Generative Construction of Future thoughts:
Figure 1. (A) Ab+ patients showed significantly more often a cognitive impairment compared with ab− patients [57.1% ... Figure 1. (A) Ab+ patients showed.
Behavior Rating Inventory of Executive Function (BRIEF2): Analyzing and Interpreting Ratings from Multiple Raters Melissa A. Messer1, MHS, Jennifer A.
Assessment Chapter 3.
Statistically-Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile AnalysiS.
Presentation transcript:

Cognitive Data in the Parkinson’s Progression Marker Initiative: Comparison of Normative Data Approaches Kathryn A. Wyman-Chick, Matthew J. Barrett, Phillip K. Martin, Carol A. Manning, & Scott A. Sperling University of Virginia Health System – Department of Neurology kateawyman@gmail.com Objective Results Table 2. Cognitive Impairment prevalence rates for participants with PD in PPMI at baseline using internal scores versus published norms by test This project examines the impact of different methods of determining normative or standardized cognitive data in the Parkinson’s Progression Markers Initiative (PPMI) dataset. There were no significant differences in age or education between the healthy control group and the PD group. Significant differences were found between internal and published norms for LNS, JLO, and semantic fluency. Compared to use of published norms, use of internal norms resulted in significantly lower standardized scores for the LNS, JLO, and semantic fluency (Table 1). The different methodologies for norming the cognitive data in PPMI resulted in different proportions of individuals identified with cognitive impairment at baseline for delayed recall, working memory, visuospatial ability, and verbal fluency (Table 2).   Impaired % Unimpaired % Internal Norms Published Norms Χ2 df p-value HVLT-R Immediate Recall 28.0 31.0 72.0 69.0 0.963 1 .326 HVLT-R Delayed Recall 15.6 32.9 84.4 67.1 34.34 <.001** LNS 21.1 6.4 78.9 93.6 38.42 < .001** JLO 8.8 5.2 91.2 94.8 4.10 .043* Semantic Fluency 22.0 14.5 78.0 85.5 8.13 .004* SDMT 29.4 26.4 70.6 73.6 .901 .343 Background Cognition is a frequent outcome measure in Parkinson’s disease (PD) research. It is important to understand underlying psychometric properties of the cognitive tests included in PPMI and approaches to comparing normative data in order to interpret the results accurately. Table 1. Comparison between PPMI Internal Norms and Published Age-Normative Data in Participants with Parkinson Disease (n=422)   Raw Scores M (SD) Test Performance Based on Internal Norms Test Performance Based on Published Age-Norms M(SD) t df p-value d HVLT-R Immediate Recall T-Score 24.44 (4.98) 46.43 (11.06) 46.34 (10.99) -0.22 421 .823 -0.008 HVLT-R Delayed Recall T-Score 8.36 (2.52) 45.99 (10.85) 46.83 (11.75) 1.44 .152 0.074 LNS Scaled Score 10.59 (2.66) 9.67 (3.10) 11.49 (2.68) 37.79 <.001** 0.574 JLO Scaled Score 12.77 (2.13) 9.47 (3.23) 12.79 (2.76) 107.04 0.737 Semantic Fluency T-Score 20.96 (5.34) 47.90 (9.95) 50.79 (9.84) 13.46 0.293 SDMT z-score 41.18 (9.73) -0.53 (0.92) -0.49 (0.86) 1.35 .177 0.042 Methods Notes: PPMI = Parkinson’s Progressive Marker Initiative; HVLT-R = Hopkins Verbal Learning Test Revised Form 1; LNS = Letter Number Sequencing; JLO = Judgment of Line Orientation Odd Numbered Items; SDMT = Symbol Digit Modalities Test Internally Normed z-scores were derived from the mean of the participant score – the group mean of the healthy control group, divided by the standard deviation of the group mean of the healthy control group for each measure. Impaired is defined as less than 1 standard deviation below the normative mean. * p ≤ .05 **p ≤ .001 Data were obtained from PPMI in January 2017. Baseline data from 422 participants with Parkinson Disease (PD) were included [Age=61.7(9.7), Education=15.6(3.0)]. Tests included Hopkins Verbal Learning Test-Revised (HVLT-R), Letter Number Sequencing (LNS), Judgment of Line Orientation (JLO), Symbol-Digit Modalities Test (SDMT), and Semantic Fluency. Internal norms were calculated for each participant using the group mean and standard deviation of the PPMI control group [Age=60.31(11.22), Education=16.04(2.89)]. Paired-sample t-tests were conducted comparing internal norms and published age-norms for each neuropsychological test. Chi-squares were conducted to evaluate the proportion of individuals with impairment (<1 SD below the mean). Conclusions Among participants with PD in PPMI, there are differences in standardized cognitive scores depending upon the normative group that is used. The use of internal norms resulted in lower standardized scores than age-norms with the exception of immediate recall. These differences impacted impairment rates across cognitive measures with the exception of learning and processing speed. Such findings indicate that standardization approaches are not interchangeable. Selection of appropriate normative comparison groups requires careful consideration, as such decisions can impact both research and clinical interpretations of cognitive data. Notes: PPMI = Parkinson’s Progressive Marker Initiative; HVLT-R = Hopkins Verbal Learning Test Revised Form 1; LNS = Letter Number Sequencing, JLO = Judgment of Line Orientation Odd Numbered Items; SDMT = Symbol Digit Modalities Test; Internally Normed z-scores were derived from the mean of the participant score – the group mean of the healthy control group, divided by the standard deviation of the group mean of the healthy control group for each measure. T-scores have a mean of 50 with a standard deviation of 10; Scaled Scores have a mean of 10 with a standard deviation of 3; z-scores have a mean of 0 with a standard deviation of 1. * p ≤ .05 **p ≤ .001 Data used in the preparation of this poster were obtained from the Parkinson’s Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data). For up-to-date information on the study, visit www.ppmi-info.org.” “PPMI – a public-private partnership – is funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners, including Abbvie, Avid Radiopharmaceuticals, Biogen, Bristol-Myers Squibb, Covance, GE Healthcare, Genetech, GlaskoSmithKline, Lilly, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Sanofi Genzyme, Servier, Teva, and UCB